FDA Peptide Reclassification 2026: What It Means for Providers The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Ozempic Knock Offs Contain Unsafe Substance Banned by FDA, Novo Finds Bloomberg BPC 157: The Real Reason Why It's Not FDA Approved Stracuzzi Wellness